skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Dendritic Cell-MART-1 Peptide Vaccine (Code C2426)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Dendritic Cell-MART-1 Peptide Vaccine

Definition: A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of MART-1 (melanoma antigen recognized by T-cells), an antigen expressed by melanoma cells. When the altered dendritic cells are returned to the patient, they stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing MART-1. (NCI04)

Display Name: Dendritic Cell-MART-1 Peptide Vaccine

Label: Dendritic Cell-MART-1 Peptide Vaccine

NCI Thesaurus Code: C2426 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0393062  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Dendritic Cell-MART-1 Peptide Vaccine
dendritic cell MART-1 peptide vaccine
MART-1 peptide-pulsed DC vaccine
MART-1 peptide-pulsed dendritic cell vaccine
Vaccine, dendritic cell-MART-1 peptide

External Source Codes: 
PDQ Closed Trial Search ID 42663
PDQ Open Trial Search ID 42663 (check for NCI PDQ open clinical trial info)
UMLS CUI C0393062

Other Properties:
     Name Value (qualifiers indented underneath)
code C2426
Contributing_Source CTRP
Legacy_Concept_Name Dendritic_Cell-MART-1_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom